Cellibre
- Company typePrivate
- Founded2017
- HeadquartersSan Diego, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
Cellibre firmographics
Firmographics- Name
- Cellibre
- Legal name
- Cellibre, Inc.
- Website
- https://cellibre.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Cellibre industry classification
Industry- Product category
- Precision Fermentation Ingredients
- NAICS
- Medicinal and Botanical Manufacturing (325411)
- SIC
- Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Fermentation-Derived Alternative Proteins Manufacturing (Precision Fermentation) (AFAKAGAH)
- akta.pro secondary industries
- Enzymes & Industrial Biotechnology Inputs (Enzymes, Microbial Strains, Fermentation Aids) (EUAAAIAL), Compostable & Bio-Based Packaging (PLA/PHA, Starch Blends, Cellulose Films) (IMALAMAB)
Keywords
Where Cellibre is headquartered
LocationHeadquarters
- HQ city
- San Diego
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Cellibre business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations
Revenue model
- Ingredient Sales (Direct B2B): Direct sale of fermentation-produced natural ingredients (Bakuchiol, Resveratrol, Naringenin) to manufacturers in beauty, food, pharmaceutical, and cosmetic industries. Revenue generated from commercial products at various stages from commercial titers to pilot/successfully piloted products.
- Strategic Partnership Revenue: Partnership agreements with major flavor and cosmetic ingredient companies like Symrise providing preferred access to proprietary technology platform for developing next-generation manufacturing technologies and high-value natural ingredients.
- Platform Development Services: Custom development and optimization services for producing specific molecules through precision fermentation. Includes strain development, process optimization, and scale-up services potentially structured as project-based or milestone payments.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom ingredient sales with quote-based pricing |
Go-to-market motion3 records
Distribution channels2 records
Marketing channels6 records
Cellibre product offering
Product offeringCore offering
Cellibre turns cells into specialized, sustainable factories for the manufacture of high-value natural ingredients at scale using precision fermentation technology. The company produces ingredients such as Bakuchiol (vegan retinol alternative for skincare), Resveratrol (multi-therapeutic polyphenol), and Naringenin (clean beauty flavonoid) by engineering microorganisms to manufacture complex organic molecules sustainably, replacing agricultural extraction with fermentation-based production.
Product overview
Cellibre operates a precision fermentation platform encompassing three named commercial/pipeline ingredients — Bakuchiol (a natural retinol replacement for skin care), Resveratrol (a multi-therapeutic ingredient targeting inflammation, cardiovascular, and neurodegenerative conditions), and Naringenin (a flavonoid for clean beauty and health applications) — plus an undisclosed Product B. The company also provides internal strain engineering, biochemistry/protein engineering, and bioprocessing-as-a-service capabilities across its platform. All products share the company's core precision fermentation technology, with some ingredients produced internally (I) and others partnered (P).
Differentiator
Problem solved
Functional benefit
Products and services
- Bakuchiol A natural, vegan retinol replacement produced via precision fermentation that helps prevent fine lines and wrinkles while improving skin firmness and elasticity. It is a less irritating alternative to traditional retinol, targeting cosmetic and skincare brands seeking clean beauty ingredients.
- Resveratrol A precision fermentation-produced polyphenol ingredient with reported anticancer, antioxidant, anti-inflammatory, immunomodulatory, glucose and lipid regulatory, neuroprotective, and cardiovascular protective effects. Targeting pharmaceutical and health supplement manufacturers for conditions including cardiovascular diseases, cancer, liver diseases, obesity, diabetes, Alzheimer's disease, and Parkinson's disease.
- Naringenin A precision fermentation-produced flavonoid with potential therapeutic benefits including antioxidant, antitumor, antiviral, antibacterial, anti-inflammatory, antiadipogenic, and cardioprotective effects. Targeted for clean beauty applications improving skin health span and flavoring/antioxidant uses.
- Product B
Quantifiable outcome
- Commercial production of Bakuchiol expected by 2025, providing sustainable alternative to retinol
- +2 more outcomes
Companies that use Cellibre
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles4 records
Cellibre technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature5 records
Cellibre partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered flagship and core.
- SymriseflagshipSymrise, a global supplier of fragrances, flavorings, cosmetic active ingredients, and functional ingredients, made a strategic equity investment in Cellibre. The partnership provides Symrise with preferred access to Cellibre's proprietary precision fermentation-based technology to develop next-generation manufacturing technologies for globally important ingredients. The collaboration aims to accelerate commercialization of high-value natural flavor ingredients and cosmetic bioactives, while helping Symrise achieve supply chain resilience and sustainability commitments.
- BioMADE (Bioindustrial Manufacturing and Design Ecosystem)coreCellibre joined BioMADE, a Department of Defense initiative and national manufacturing innovation institute for industrial biotechnology. The partnership focuses on advancing sustainable biomanufacturing technologies through workshops, knowledge sharing, and ecosystem collaboration.
Scale indicators5 records
Recent moves6 records
Expansion highlights6 records
Cellibre competitors and assessment
Company assessmentDirect peers
- Conagen: Conagen is a precision fermentation company producing high-value ingredients including flavors, fragrances, vitamins, and cosmetics actives using its own strain engineering platform. It is the closest direct peer to Cellibre given its similar organism-agnostic approach and focus on sustainable natural ingredient production via fermentation.
- Amyris: Amyris used precision fermentation to produce specialty ingredients including squalene, resveratrol, and other botanical molecules for cosmetics and flavors, and filed for bankruptcy in 2023. It is the canonical cautionary comparable for Cellibre, sharing the same technology paradigm and end-markets but illustrating the execution risks of scaling fermentation-derived ingredients.
Broad incumbents
- Ginkgo Bioworks: Ginkgo Bioworks is a well-capitalized synthetic biology platform that programs cells for industrial applications across flavors, fragrances, cosmetics, and food ingredients. It competes for the same end-customer relationships and has acquired Zymergen, making it a broad incumbent with vastly greater resources than Cellibre.
Emerging players
- Eve Bio (formerly Lygos): Lygos rebranded as Eve Bio and focuses on producing specialty chemicals and bio-based ingredients via precision fermentation, including organic acids and cannabinoid precursors. It overlaps with Cellibre's fermentation-derived natural ingredient strategy and shares a similar scale and emerging commercial stage.
- Checkerspot: Checkerspot uses precision fermentation to produce novel oils and polyols for cosmetics, personal care, and performance materials. It directly competes with Cellibre in fermentation-derived cosmetic actives and shares a similar end-market focus on clean beauty and sustainable ingredients.
- Motif FoodWorks: Motif FoodWorks develops fermentation-derived ingredients for taste, texture, and nutrition applications in plant-based and alternative food products. It is comparable to Cellibre's Ajinomoto NGT3 win pathway, addressing food and nutrition ingredient markets through precision fermentation.
- Perfect Day: Perfect Day produces animal-free dairy proteins (whey and casein) using precision fermentation, supplying major CPG and food service companies. It is a leading commercial-stage precision fermentation peer and validates the broader market acceptance of fermentation-derived ingredients.
- C16 Biosciences: C16 Biosciences uses precision fermentation to produce sustainable palm oil alternatives for the cosmetics and food industries. It overlaps with Cellibre's value proposition of replacing plant extraction with fermentation and serves similar clean beauty and sustainability-focused end customers.
- Cradle: Cradle offers AI-driven protein design and engineering software for biotech applications including industrial enzymes and therapeutics. It is comparable to Cellibre's Anax platform as a competitor or potential partner in the AI-driven enzyme and protein optimization layer of precision fermentation.
Others
- Culture Biosciences: Culture Biosciences provides fermentation-as-a-service and high-throughput fermentation screening infrastructure to biotech companies. It is an enabling service provider rather than direct competitor but is comparable to Cellibre's high-throughput fermentation screening and pilot-scale capabilities.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Cellibre social profiles
Digital presenceCellibre financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cellibre leadership team
Management profileNumber of profiles
Profiles4 records
Cellibre funding detail
Funding detailFunding overview
Funding rounds5 records
Investors10 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cellibre M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cellibre
What does Cellibre do?
Cellibre turns cells into specialized, sustainable factories for the manufacture of high-value natural ingredients at scale using precision fermentation technology. The company produces ingredients such as Bakuchiol (vegan retinol alternative for skincare), Resveratrol (multi-therapeutic polyphenol), and Naringenin (clean beauty flavonoid) by engineering microorganisms to manufacture complex organic molecules sustainably, replacing agricultural extraction with fermentation-based production.
Is Cellibre a public or private company?
Cellibre is a private company. It is classified as venture growth investor backed and is currently operating.
When was Cellibre founded?
Cellibre was founded in 2017. It employs 11 to 50 people.
Where is Cellibre based?
Cellibre is headquartered in San Diego, United States, in the North America region.
How does Cellibre make money?
Three revenue lines are on record. Ingredient Sales (Direct B2B) is the primary driver. The others are strategic Partnership Revenue and platform Development Services.
Who are Cellibre's main competitors?
Direct peers on record are Conagen and Amyris. Ginkgo Bioworks is listed as a broad incumbent. Emerging players are Eve Bio (formerly Lygos), Checkerspot, Motif FoodWorks, Perfect Day, C16 Biosciences and Cradle. Culture Biosciences is listed as an others.
Does Cellibre have an API?
No public API is recorded for Cellibre.
What industry is Cellibre in?
Cellibre's product category is Precision Fermentation Ingredients. Its primary akta.pro industry code is AFAKAGAH, Fermentation-Derived Alternative Proteins Manufacturing (Precision Fermentation), with a secondary code of EUAAAIAL, Enzymes & Industrial Biotechnology Inputs (Enzymes, Microbial Strains, Fermentation Aids). Its NAICS code is 325411 and its SIC code is 2833.